Apollo Hospitals Enterprise share price
NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap
Apollo Hospitals Enterprise Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,137.00up ₹345.50 (4.43%)BSE ₹8,140.00
Share price at the NSE close on 28 Oct 2026. Previous close ₹7,791.50.
28 Oct: open ₹7,800.00, high ₹8,151.00, low ₹7,714.50
52-week range of traded prices to 28 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,16,998 Cr97th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 55.99
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 12.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.25%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 23.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.57
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 7,63,970
About Apollo Hospitals Enterprise
Apollo Hospitals Enterprise Limited runs a network of multi-speciality and super-speciality hospitals across India.1 Around its hospitals it has built pharmacies, diagnostic centres, primary care clinics and an online platform for consultations, medicine orders and diagnostics.21 It serves patients from cities and villages in India and from abroad.3
The business is reported in segments: Healthcare Services (hospitals), Apollo Health and Lifestyle (AHLL: diagnostics, primary care and specialised healthcare services) and Apollo HealthCo (pharmacy distribution and the Apollo 24|7 digital platform).45 It provides services in 28 states and 4 union territories, and patients come to its hospitals from 150 countries, the company says.36
It was incorporated in 1979; Prathap C Reddy founded Apollo Hospitals as a corporate hospital in 1983.78 In the year to Mar 2026 it bought out the stake of International Finance Corporation (IFC) and an IFC fund in AHLL for ₹12,540.68 million and the remaining shares from individual holders for ₹186.95 million, and AHLL became a wholly owned subsidiary.9
Prathap C Reddy is Chairman, and his daughters Suneeta Reddy and Sangita Reddy are Managing Director and Joint Managing Director; the company classes them as promoters.101112 It owns 99.68% of Apollo HealthCo and holds 22.03% of Indraprastha Medical Corporation, an associate company.1314
Apollo Hospitals Enterprise key points
Results
- In the year to Mar 2026, consolidated revenue was ₹25,229 crore and consolidated EBITDA (earnings before interest, tax, depreciation and amortisation) ₹3,769 crore. Consolidated revenue from operations rose 16%, and the group's profit after tax rose 33% to ₹20,027 million.1516
- In the quarter to Jun 2026, consolidated revenue rose 21% to ₹7,043 crore, EBITDA rose 28% to ₹1,092 crore and profit after tax rose 34% to ₹581 crore, on a year earlier.1718
Business segments
- Revenue by segment, year to Mar 202619
Item year to Mar 2026 Healthcare Services ₹12,555 crore Apollo HealthCo ₹10,808 crore Apollo Health and Lifestyle (AHLL) ₹1,865 crore - Healthcare Services (hospitals). Revenue rose 22% to ₹3,567 crore in the quarter to Jun 2026, and EBITDA rose 20% to ₹862 crore, an EBITDA margin of 24.2%. New hospitals made an EBITDA loss of ₹38 crore.2021
- Apollo HealthCo (pharmacy distribution and digital health). Revenue rose 20% to ₹2,977 crore in the quarter to Jun 2026, and EBITDA was ₹171 crore against ₹94 crore a year earlier.22
- Apollo Health and Lifestyle (AHLL). Revenue rose 15% to ₹499 crore in the quarter to Jun 2026 and EBITDA rose 46% to ₹59 crore.23
Hospitals and patients
- At the end of March 2026 the group had 78 hospitals, including managed ones, with 10,970 capacity beds, of which 9,620 were operational.2425
- In the quarter to Jun 2026, the hospitals' inpatient volumes rose 13% on a year earlier, occupancy was 70% and average revenue per inpatient rose 8% to ₹186,630.26
- Insurance and self-paying patients brought 83% of the hospitals' inpatient net revenue in the quarter to Jun 2026; cardiac, oncology, transplant, neurosciences, gastroenterology and orthopaedics (CONGO-T) brought 62%.27
- International patients brought 6% of the hospitals' inpatient revenue in the year to Mar 2026, and revenue from them grew 26% in the quarter to Jun 2026.2829
Branches and reach
- Apollo HealthCo served 7,440 pharmacy stores at the end of June 2026.30
- Apollo 24|7, the group's digital platform, had more than 49 million registrations and about 53,000 daily medicine orders, its presentation of 12 Aug 2026 shows.313233
- AHLL ran 172 dialysis centres and 294 dental centres at the end of June 2026.34
Expansion and capital spending
- In the half year to Jun 2026 the company commissioned 5 new hospitals with about 1,000 census beds (inpatient beds); excluding Gurgaon, 380 were in operation, and the other 620 are to follow over 12 to 18 months.3536
- In the year to Mar 2026 it spent ₹18,096 million of capital expenditure on hospitals. The expansion projects in its presentation of 12 Aug 2026 have a total cost of about ₹11,150 crore.3738
- On its earnings call of 13 Aug 2026, the company said its expansion plans to the year to Mar 2031 would take its census bed capacity to 14,100 beds, funded largely from its own earnings.39
What the company expects
- On its earnings call of 13 Aug 2026, the company said its established hospitals would continue to grow at 13% to 14% and new hospitals would bring an additional 7% of revenue, a target it called sustainable for the next 24 months.40
- On its earnings call of 13 Aug 2026, the company said its digital business, after a cash loss of ₹10 crore in the quarter to Jun 2026, was poised to break even in the following quarter, which ended in September; its documents give no outcome.41
Pharmacy business demerger
- Under a composite scheme of arrangement approved by the board on 30 Jun 2025, the pharmacy distribution, Apollo 24|7 and telehealth businesses are to be demerged (split off) into Apollo Healthtech Limited, which is to absorb Apollo HealthCo and Keimed.4243
- The Competition Commission of India approved the scheme on 23 Sep 2025, and the company's shareholders and creditors approved it on 24 Jun 2026 at meetings convened by the National Company Law Tribunal (NCLT).4445
- On its earnings call of 13 Aug 2026, the company said it expects the scheme to conclude in the year to Mar 2027, after which Apollo Healthtech is to apply for a stock exchange listing.4647
- In its presentation of 12 Aug 2026, the company said it expects the proposed new company to reach an annualised revenue run rate of ₹250 billion in the quarter to Mar 2027.48
Recent events
- On 20 May 2026, the board approved selling AHLL's mother-and-child and fertility businesses to Kids Clinic India (Cloudnine), valued at about ₹15,500 million, for ₹7,650 million in cash and a 9.9% stake. Regulatory clearance was awaited on 13 Aug 2026.4950
- On 18 May 2026, ICRA affirmed its AAA (Stable) rating on the company's long-term bank facility and instrument and its A1+ short-term rating; a rating is an agency's view of ability to repay.51
Last updated
All 51 sources, each with its page
- 1. Annual report, 28 Aug 2026, page 10
- 2. Annual report, 28 Aug 2026, page 81
- 3. Annual report, 28 Aug 2026, page 233
- 4. Annual report, 28 Aug 2026, page 82
- 5. Annual report, 28 Aug 2026, page 83
- 6. Earnings call, 13 Aug 2026, page 4
- 7. Annual report, 28 Aug 2026, page 1
- 8. Annual report, 28 Aug 2026, page 81
- 9. Annual report, 28 Aug 2026, page 44
- 10. Annual report, 28 Aug 2026, page 40
- 11. Annual report, 28 Aug 2026, page 54
- 12. Annual report, 28 Aug 2026, page 54
- 13. Annual report, 28 Aug 2026, page 236
- 14. Annual report, 28 Aug 2026, page 237
- 15. Annual report, 28 Aug 2026, page 5
- 16. Annual report, 28 Aug 2026, page 41
- 17. Earnings call, 13 Aug 2026, page 2
- 18. Earnings call, 13 Aug 2026, page 3
- 19. Annual report, 28 Aug 2026, page 5
- 20. Earnings call, 13 Aug 2026, page 2
- 21. Earnings call, 13 Aug 2026, page 3
- 22. Earnings call, 13 Aug 2026, page 3
- 23. Earnings call, 13 Aug 2026, page 3
- 24. Annual report, 28 Aug 2026, page 81
- 25. Annual report, 28 Aug 2026, page 82
- 26. Earnings call, 13 Aug 2026, page 2
- 27. Earnings call, 13 Aug 2026, page 2
- 28. Annual report, 28 Aug 2026, page 85
- 29. Earnings call, 13 Aug 2026, page 2
- 30. Investor presentation, 12 Aug 2026, page 8
- 31. Annual report, 28 Aug 2026, page 84
- 32. Investor presentation, 12 Aug 2026, page 28
- 33. Investor presentation, 12 Aug 2026, page 28
- 34. Investor presentation, 12 Aug 2026, page 7
- 35. Investor presentation, 12 Aug 2026, page 13
- 36. Investor presentation, 12 Aug 2026, page 15
- 37. Annual report, 28 Aug 2026, page 86
- 38. Investor presentation, 12 Aug 2026, page 15
- 39. Earnings call, 13 Aug 2026, page 3
- 40. Earnings call, 13 Aug 2026, page 13
- 41. Earnings call, 13 Aug 2026, page 3
- 42. Annual report, 28 Aug 2026, page 83
- 43. Annual report, 28 Aug 2026, page 41
- 44. Annual report, 28 Aug 2026, page 41
- 45. Exchange filing, 26 Jun 2026, page 1
- 46. Earnings call, 13 Aug 2026, page 4
- 47. Investor presentation, 12 Aug 2026, page 30
- 48. Investor presentation, 12 Aug 2026, page 32
- 49. Exchange filing, 20 May 2026, page 3
- 50. Earnings call, 13 Aug 2026, page 14
- 51. Exchange filing, 19 May 2026, page 1
Results
Consolidated; ₹ crore.Apollo Hospitals Enterprise quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +17.2%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +32.8%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹7,044 Crup 6.63%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹610 Crup 10.72%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.7%
Revenue by quarter
Peak revenue ₹7,044 Cr, quarter to Jun 2026; lowest ₹5,527 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5,589 | 5,527 | 5,592 | 5,842 | 6,304 | 6,477 | 6,606 | 7,044 |
| Net profit | 396 | 379 | 415 | 441 | 494 | 516 | 551 | 610 |
| Net margin | 7.1% | 6.9% | 7.4% | 7.5% | 7.8% | 8.0% | 8.3% | 8.7% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹25,229 Crup 15.76%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹2,003 Crup 33.06%
- Net margin
- 7.9%
Revenue by year
Peak revenue ₹25,229 Cr, year to Mar 2026; lowest ₹7,255 Cr, year to Mar 2017
Net profit by year, a loss in red
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,255 | 8,243 | 9,617 | 11,247 | 10,560 | 14,663 | 16,612 | 19,059 | 21,794 | 25,229 |
| Net profit | 221 | 60 | 200 | 432 | 137 | 1,108 | 845 | 935 | 1,505 | 2,003 |
| Net margin | 3.0% | 0.7% | 2.1% | 3.8% | 1.3% | 7.6% | 5.1% | 4.9% | 6.9% | 7.9% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- Healthcare servicesHealthcare services, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹12,750 Crup 13.64%50.1%
- Digital health & pharmacy distributionDigital health & pharmacy distribution, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹10,808 Crup 18.86%42.5%
- Retail health and diagnosticsRetail health and diagnostics, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,865 Crup 20.07%7.3%
- OthersOthers, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹5 Cr0.0%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history.Apollo Hospitals Enterprise PE ratio and valuation
Price to earnings
At or below today's level on 10% of 2,285 trading days over the last 10 years.
LowestHighest
Its median69.81Industry median42.88
Price to book
At or below today's level on 60% of 1,971 trading days since Nov 2018.
LowestHighest
Its median11.79Industry median4.47
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 36% of 2,475 trading days over the last 10 years.
LowestHighest
Its median0.27%Industry median0.24%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +12.4% | +34.3% | −16.5% | 0.3% |
| 3 years | +20.1% | +33.3% | −10.1% | 0.3% |
| 5 years | +20.9% | +65.9% | −27.3% | 0.3% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 5 years includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the year to Mar 2021.
Mutual fund holdings
401 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 164 of the 231 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 5 more funds filed their first portfolio on record, holding it.All 401 funds holding Apollo Hospitals Enterprise
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 9
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 8
- AddedAdded. Funds that held more shares than at the end of the month before.
- 120
- CutCut. Funds that held fewer shares than at the end of the month before.
- 111
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 148
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 11
| Fund | |||
|---|---|---|---|
 SBI Nifty 50 ETFSBI Mutual Fund | 19,96,066 | 0.80% | ₹1,629.9 Cr |
 HDFC Flexi Cap FundHDFC Mutual Fund | 10,54,093 | 0.79% | ₹860.7 Cr |
 Axis Large Cap FundAxis Mutual Fund | 10,40,646 | 2.91% | ₹849.7 Cr |
 ICICI Prudential Balanced Advantage FundICICI Prudential Mutual Fund | 6,97,048 | 0.79% | ₹569.2 Cr |
 UTI Nifty 50 ETFUTI Mutual Fund | 6,84,525 | 0.80% | ₹558.9 Cr |
| Axis Focused FundAxis Mutual Fund | 6,49,263 | 5.06% | ₹530.2 Cr |
 Nippon India ETF Nifty 50 BeESNippon India Mutual Fund | 6,40,774 | 0.80% | ₹523.2 Cr |
| SBI Flexicap FundSBI Mutual Fund | 5,65,751 | 2.09% | ₹462.0 Cr |
 Franklin India Flexi Cap FundFranklin Templeton Mutual Fund | 5,62,115 | 2.52% | ₹459.0 Cr |
| Nippon India Pharma FundNippon India Mutual Fund | 5,48,795 | 4.89% | ₹448.1 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 28 Oct 2025.Apollo Hospitals Enterprise insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 2 pledges created · 2 pledges released · 3 off-market moves
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Apollo Hospitals Enterprise competitors and peers
Hospital, 39 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Apollo Hospitals Enterprise in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Manipal Health EnterprisesMANIPALHOS | 84,612 | – | – | – | – | – | – | 0.00% |
 Max Healthcare InstituteMAXHEALTH | 82,877 | 56.87 | 7.71 | +16.0% | +27.0% | 14.5% | 13.0% | 0.23% |
 Aster DM Quality CareASTERDM | 58,354 | 183.11 | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.45% |
 Fortis HealthcareFORTIS | 57,339 | 54.72 | 5.79 | +17.5% | +20.7% | 11.1% | 12.7% | 0.13% |
 Narayana HrudayalayaNH | 35,213 | 43.15 | 7.76 | +57.8% | +3.9% | 20.0% | 13.1% | 0.26% |
 Global HealthMEDANTA | 34,497 | 62.02 | 8.71 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 29,594 | 144.71 | 13.17 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,063 | 101.53 | 7.44 | – | – | 7.6% | 14.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Apollo Hospitals Enterprise dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹20.00 a share, year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 14 Aug 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹10.00 |
| 16 Feb 2026 | Interim | ₹10.00 |
| 19 Aug 2025 | Final | ₹10.00 |
| 14 Feb 2025 | Interim | ₹9.00 |
| 16 Aug 2024 | Final | ₹10.00 |
| 20 Feb 2024 | Interim | ₹6.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Apollo Hospitals Enterprise announcements
Oct 2026
16 Oct
15 Oct · Analysts
Sep 2026
3 Sep
Aug 2026
Apollo Hospitals Enterprise share price by year
Each calendar year to 2025.Apollo Hospitals Enterprise share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 7,042.50 | −3.5% | 8,012.00 | 6,052.60 |
| 2024 | 7,296.35 | +27.9% | 7,424.85 | 5,682.00 |
| 2023 | 5,704.10 | +27.4% | 5,760.50 | 4,200.95 |
| 2022 | 4,477.60 | −10.7% | 5,065.25 | 3,524.30 |
| 2021 | 5,013.40 | +107.8% | 5,733.95 | 2,409.25 |
| 2020 | 2,412.80 | +67.3% | 2,463.00 | 1,088.85 |
| 2019 | 1,442.00 | +14.6% | 1,536.80 | 1,116.40 |
| 2018 | 1,258.30 | +4.4% | 1,292.20 | 927.10 |
| 2017 | 1,204.80 | +2.1% | 1,352.50 | 985.95 |
| 2016 | 1,179.90 | −19.5% | 1,498.40 | 1,126.00 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 7,818.00 | 7,965.00 | 7,791.50 | 7,791.50 | 7,886.45 | 4,80,773 | 56.2% |
| 26 Oct 2026 | 7,719.00 | 7,844.00 | 7,634.00 | 7,844.00 | 7,727.47 | 4,14,155 | 50.1% |
| 23 Oct 2026 | 7,600.00 | 7,740.00 | 7,550.00 | 7,730.00 | 7,655.53 | 4,96,460 | 46.0% |
| 22 Oct 2026 | 7,505.00 | 7,648.00 | 7,465.00 | 7,604.50 | 7,580.55 | 4,18,903 | 57.3% |
| 21 Oct 2026 | 7,750.00 | 7,780.00 | 7,560.00 | 7,600.00 | 7,622.37 | 2,66,377 | 60.9% |
| 19 Oct 2026 | 7,880.50 | 7,895.00 | 7,664.50 | 7,700.00 | 7,747.27 | 4,22,465 | 61.9% |
| 16 Oct 2026 | 7,928.00 | 7,928.00 | 7,795.00 | 7,890.00 | 7,849.01 | 5,47,599 | 69.8% |
| 15 Oct 2026 | 7,812.00 | 7,966.50 | 7,767.50 | 7,889.50 | 7,898.16 | 4,39,956 | 57.1% |
| 14 Oct 2026 | 7,825.50 | 7,889.50 | 7,697.00 | 7,824.00 | 7,822.81 | 5,46,866 | 58.1% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 2 Sep 2010 | Split | 0.5000 | Each share became 2. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- APOLLOHOSP
- BSE code
- 508869
- ISIN
- INE437A01024
- Industry
- Healthcare Services
- Website
- www.apollohospitals.com
- CIN
- L85110TN1979PLC008035
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1979
- Registered office
- No.19, Bishop Gardens, Raja Annamalaipuram, Chennai 600028, Tamil Nadu
- Share registrar
- Integrated Registry Management Services Pvt. Ltd (Integrated Enterprises (India) Ltd)
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 50, Nifty 100, BSE 100, Nifty 200, BSE 200, Nifty 500